BILINSKY IGOR 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
BILINSKY IGOR
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-02+12,307→ 118,051 total - Tax Payment
Common Stock
[F2][F3]2026-03-02$3.79/sh−6,903$26,162→ 111,148 total - Exercise/Conversion
Restricted Stock Units
[F4][F5][F6]2026-03-02−8,790→ 35,159 total→ Common stock (8,790 underlying) - Exercise/Conversion
Restricted Stock Units
[F4][F5][F7]2026-03-02−3,517→ 0 total→ Common stock (3,517 underlying)
Footnotes (7)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
- [F7]Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.
Signature
/s/ Igor Bilinsky|2026-03-04